ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections

This study has been completed.

Study NCT00035945 Information provided by Isis Pharmaceuticals

First Received: May 6, 2002 Last Updated: October 15, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given